Myocardial Infarction (MI): Clinical Trials

2 trials for Myocardial Infarction (MI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Not yet recruiting 1, Recruiting 1

Follow Myocardial Infarction (MI): new trials by email Literature Review of Myocardial Infarction (MI) trials Research Report on Myocardial Infarction (MI)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months
Prasugrel, Ticagrelor - Myocardial Infarction (MI)
Phase 4RecruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz81002026-09-022026-09-09
Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor
Rifaximin - ACS - Acute Coronary Syndrome, Ticagrelor
Phase 4Not yet recruitingCollegium Medicum w Bydgoszczy502026-01-012025-10-02

Narrower conditions

Acute Coronary Syndrome (2)  ·  Myocardial Infarction (2)  ·  Dysbiosis (1)  ·  Hemorrhage (1)  ·  Infarction (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Ischemia (2)  ·  Myocardial Ischemia (2)  ·  Necrosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Infarction (1)

Interventions

Prasugrel Hydrochloride (1)  ·  Rifaximin (1)  ·  Ticagrelor (1)

Sponsors

Collegium Medicum w Bydgoszczy (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)

Countries

Poland (2)  ·  Ireland (1)  ·  Latvia (1)  ·  Norway (1)  ·  Spain (1)

Top investigators

Borja Ibanez, MD PhD (1)  ·  Jacek Kubica, Prof. (1)